xtandi
astellas pharma europe b.v. - enzalutamide - prostatické nádory - endokrinná terapia - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
aurorix 150 mg
viatris healthcare limited, Írsko - moklobemid - 30 - antidepressiva
syntostigmin
zentiva a.s., slovensko - neostigmín - 67 - parasympathomimetica
timonil retard 150 mg
desitin arzneimitttel gmbh, nemecko - karbamazepín - 21 - antiepileptica, anticonvulsiva
ketonal 100 mg/2 ml
sandoz pharmaceuticals d.d., slovinsko - ketoprofén - 29 - antirheumatica, antiphlogistica, antiuratica
amitriptylin-slovakofarma
zentiva a.s., slovensko - amitriptylín - 30 - antidepressiva
seroxat 20 mg
glaxosmithkline trading services limited, Írsko - paroxetín - 30 - antidepressiva
seroxat 30 mg
glaxosmithkline trading services limited, Írsko - paroxetín - 30 - antidepressiva
fevarin 50
viatris healthcare limited, Írsko - fluvoxamín - 30 - antidepressiva
fevarin 100
viatris healthcare limited, Írsko - fluvoxamín - 30 - antidepressiva